Corteva, Inc. has released its financial results for the second quarter ended June 30, 2024. The company reported a 1% increase in net sales year-over-year, with organic sales rising by 2%. The volume remained flat compared to the prior year, as growth in Crop Protection counterbalanced declines in Seed volumes. Notably, Crop Protection volume surged by 6%, driven by demand in Latin America and North America for new products and spinosyns, although this was partially offset by residual destocking and adverse weather conditions in EMEA. Seed volume declined by 2% due to earlier seasonal deliveries in North America and a delayed season in EMEA.
The price increased by 2% compared to the previous year, attributed to Corteva’s price-for-value strategy and an improved product mix in Seed. However, this was partly countered by competitive pricing pressures in Crop Protection. GAAP income from continuing operations reached $1.06 billion for Q2 2024, up from $880 million in Q2 2023. Operating EBITDA for the quarter was $1.92 billion, marking a 10% increase from the previous year and reflecting an improvement of approximately 250 basis points in margin.
In Q2 2024, Seed net sales amounted to $4.33 billion, up from $4.26 billion in Q2 2023. This increase was driven by a 5% rise in price, though partially offset by a 2% decline in volume and a 1% unfavorable impact from portfolio changes. The price increase was widespread, particularly in North America, due to an improved product mix and the company’s pricing strategy. However, lower volumes were influenced by earlier seasonal deliveries in North America and a delayed season in EMEA.
Segment operating EBITDA for Seed was $1.70 billion, a 16% increase from Q2 2023, thanks to effective price execution, reduced net royalty expenses, and ongoing cost and productivity initiatives. Segment operating EBITDA margin improved by approximately 500 basis points compared to the prior year. For the first half of 2024, Seed net sales totaled $7.1 billion, up from $7.0 billion in the first half of 2023, with a 5% increase in price offset by a 1% decline in volume and unfavorable currency impacts.
Crop Protection net sales were approximately $1.8 billion in Q2 2024, unchanged from Q2 2023. The flat sales performance resulted from a 6% increase in volume, which was balanced by a 5% decrease in price and a 1% adverse impact from currency fluctuations. The volume growth was primarily driven by Latin America and North America due to new products and spinosyns, though it was partially negated by residual destocking and poor weather in EMEA. The decline in price was widespread due to competitive pressures in the global Crop Protection market.
For the first half of 2024, Crop Protection net sales were about $3.5 billion, down from $4.0 billion in the first half of 2023. This decrease was due to a 7% drop in volume, a 4% decline in price, and a 1% unfavorable impact from currency, partially offset by a 1% favorable portfolio impact. Segment operating EBITDA for this period was $565 million, reflecting a 39% decline from the previous year, primarily due to pricing pressures, raw material cost inflation, and unfavorable currency impacts.
Looking ahead, Corteva expects net sales for 2024 to be in the range of $17.2 billion to $17.5 billion, marking a 1% growth at the midpoint. The company projects operating EBITDA to range from $3.4 billion to $3.6 billion, representing a 4% increase at the midpoint. Operating EPS is forecasted to be between $2.60 and $2.80 per share. Cash provided by operating activities is anticipated to range from $2.1 billion to $2.6 billion, while Free Cash Flow is expected to be between $1.5 billion and $2.0 billion. Additionally, Corteva plans to repurchase approximately $1.0 billion in shares during 2024.